Niccolo Pengo

Niccolo Pengo

Company: Mabylon

Job title: Chief Scientific Officer


Novel Antibodies Targeting the Inflammasome to Treat Neurodegeneration 2:30 pm

Discuss how the inflammasome is a promising target in neurodegenerative diseases Learn how Mabylon has identified novel monoclonal antibodies that hold promise for the treatment of neurodegenerationRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.